| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Feb 2026 | 27 Jan 2026 |
| Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited financial results for the Quarter ended 31st December 2025. The Board of Directors of the Company will be held on Friday, 13 February, 2026 at 4.00 P.M. /nter alia, to consider and approve the unaudited financial results of the Company for the Quarter ended December 31st, 2025 and to recommend payment of dividend on equity shares, if any. (As Per BSE Announcement Dated on:27.01.2026) Result For Quarter ended Dec 2025 (As Per BSE Announcement Dated on:13.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 24 Oct 2025 |
| Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited financial results for the half year ended 30th September, 2025 Submission of the unaudited financial results for Quarter and half year ended, 30th September, 2025 (As Per BSE Announcement Dated on: 14/11/2025) | ||
| Board Meeting | 14 Aug 2025 | 6 Aug 2025 |
| Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Board Meeting Intimation for Unaudited financial results for the quarter ended 30th June 2025 Unaudited financial results for the quarter ended 30th June, 2025 and to recommend payment of dividend if any. Submission of the unaudited financial results for Quarter ended, 30th June, 2025 (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 2 Jul 2025 | 2 Jul 2025 |
| Intimation of Reappointment of MD and WTD and Appointment of Secretarial Auditor and Internal Auditor | ||
| Board Meeting | 30 May 2025 | 17 May 2025 |
| Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Prior Intimation of Board Meeting to consider Audited Financial Results for the quarter and financial year ended March 31 2025. Outcome of the Board Meeting held on Friday, 30th May, 2025 (As Per BSE Announcement Dated on: 30/05/2025) Revised Result for FY 31/03/2025 (As Per BSE Announcement dated on 04.06.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
